期刊文献+

高效液相色谱串联质谱法测定人血浆中吲达帕胺浓度及生物等效性研究 被引量:2

Determination of Indapamide in human plasma by liquid chromatography tandem mass spectrum and study on its bioequivalence
下载PDF
导出
摘要 目的:建立一种简单、有效且灵敏的液质联用法(LC-MS/MS)检测人血浆中吲达帕胺浓度。方法:血浆样品经叔丁基甲基醚(tert-ButylMethyl Ether,MTBE)萃取后,选安定作内标。色谱柱为Luna C18柱(150mm×2.0mm,5μm);流动相为10mmol/L甲酸铵(含0.1%甲酸):甲醇=(20∶80,V/V);流速为0.30mL/min;采用ESI+MRM方式监测;源电压:3.5kV;源温度:100℃;吲达帕胺和安定的离子选择通道分别为:m/z 366.2→132.1,285.2→154.1。结果:吲达帕胺线性范围为0.536~45.733ng/mL,最低检测浓度为0.536ng/mL,提取回收率在69%~81%,日内、日间RSD均<15%。由湖南协力药业有限公司生产生产的吲达帕胺缓释片(1.5mg/片)与施维雅(天津)制药有限公司生产的吲达帕胺缓释片(商品名:纳催离,1.5mg/片)经单次及多次给药试验研究,具有生物等效性。结论:本方法简单、灵敏,可准确检测人体血浆中吲达帕胺的浓度。 AIM: To establish a simple,effective and sensitive LC-MS/MS assay to determine Indapamide in human plasma.METHODS: Diazepam was used as an internal standard.Human plasma samples were extracted by MTBE(tert-Butyl Methyl Ether).The separation was carried out on a Luna C18(150 mm×2.0 mm,5 μm) column.The mobile phase consisted of 10 mmol/L ammonium formate with 0.1% formic acid:methanol(20∶80,V/V) at a flow rate of 0.30 mL/min.Electrospray ionization(ESI) source was applied and operated in the positive ion mode.The MS detection parameters were as follows: the source voltage was 3.5 KV and source temperature was 100 ℃.Quantitation was performed using multiple reaction monitoring(MRM) of the m/z 366.2→132.1 for Indapamide and 285.2→154.1 for diazepam.RESULTS:The liner calibration curves were obtained in the range of 0.536-45.733 ng/mL for Indapamide.The lower limit of quantification was 0.536 ng/mL.The mean relative recovery was 69%~81% and the relative standard deviation of the intra-day and inter-day precision of variation were less than 15%.By single and multiple doses studies,we can demonstrate that Indapamide sustained release tablets(1.5 mg/tablet) produced by Hunan Xieli Pharmaceutical Co.,Ltd and Servier(Tianjin) Pharmaceutical Co.,Ltd are bioequivalent.CONCLUSION: This method which is simple and sensitive can be used to determinate the concentration of Indapamide in human plasma.
出处 《中国临床药理学与治疗学》 CAS CSCD 2012年第10期1157-1162,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 LC-MS MS 吲达帕胺 药物动力学 生物等效性 LC-MS/MS Indapamide Pharmacokinetics Bioequivalence
  • 相关文献

参考文献11

二级参考文献29

  • 1佟玲,齐丹丹,毕开顺,陈晓辉.高效液相色谱-串联质谱法测定人血浆中吲哒帕胺及其生物等效性研究[J].中国新药与临床杂志,2006,25(11):851-855. 被引量:4
  • 2钟大放.以加权最小二乘法建立生物分析标准曲线的若干问题[J].药物分析杂志,1996,16(5):343-346. 被引量:580
  • 3夏春华,王晓华,熊玉卿,章新晶.高效液相-质谱法测定人体血浆中吲哒帕胺的浓度及其生物等效性研究[J].中国现代应用药学,2007,24(2):136-138. 被引量:6
  • 4M. Chaffman,RC Heel, RN Brogden, et al. Indapamide, A review of its pharmacodynamic properties and therapeutic efficacy in hypertension[J]. Drugs, 1984,28 : 189.
  • 5Gastone Leonetti. Clinical positioning of indapamide sustained release 1.5rag in management protocols for hypertension[J]. Drugs,2000,59 ; 27.
  • 6Deepak SJ, Gunta Subbaiah, Mallika Sanyal,et al. Liquidchromatography-tandem mass spectrometry validated method for the estimation of indapamide in human whole blood[J]. Journal of Chromatography B, 2006,834 : 149-154.
  • 7Legorburu MJ,Alonso RM,Jimenez RM,et al.Quantitative determination of indapamide in phar-maceuticals and urine by high-performance liquidchromatography with amperometric detection[J].JChromatogr Sci,1999,37(6):283-287.
  • 8Hang TJ,Zhao W,Liu J,et al.A selective HPLCmethod for the determination of indapamide in hu-man whole blood:application to a bioequivalencestudy in Chinese volunteers[J].J Pharm Biomed A-nal,2006,40(1):202-205.
  • 9Florin A,Cristina G,Victor D,et al.Liquid chro-matography-electrospray tandem mass spectrometrymethod for determination of indapamide in serum forsingle/multiple dose bioequivalence studies of sus-tained release formulations[J].J Chromatogr B,2005,816(1):35-40.
  • 10Matuszewski BK,Constanzer ML,Chavez-EngCM.et al.Strategies for the assessment of matrixeffect in quantitative bioanalytical methods based onHPLC-MS/MS[J].Anal Chem,2003,75(13):3019-3030.

共引文献18

同被引文献14

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部